| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/01/2012 | CN102337264A siRNA sequence for inhibiting capripoxvirus P32 gene in targeted way and application of siRNA |
| 02/01/2012 | CN102337263A siRNA (Small interfering ribonucleic acid) capable of inhibiting expression of enterovirus 71 type gene, composition and application |
| 02/01/2012 | CN102337251A Chimaera for HK97 bacteriophage virus-like particle and application of chimaera |
| 02/01/2012 | CN102337218A Factor for regulating toxicity of Candida albicans and its application |
| 02/01/2012 | CN102336835A Fusion protein of interleukin-3 derived fragment and purpose thereof |
| 02/01/2012 | CN102336833A CHD1L-TCTP binding blocking agent as well as medical combination with same and application thereof |
| 02/01/2012 | CN102336822A Truncate human papilloma virus (HPV) 58 type L1 protein |
| 02/01/2012 | CN102336815A Treatment of viral infections |
| 02/01/2012 | CN102336802A Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method |
| 02/01/2012 | CN102335440A Two gene vaccines containing different CpG (cytidine-phosphatte-guanonine) sequences PCV2 (porcine circovirus 2)-ORF2 and preparation process thereof |
| 02/01/2012 | CN102335439A HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 02/01/2012 | CN102335438A Application of recombinant plasmid containing HIPK2 (homedomain interacting protein kinase 2) gene for preparing anti-tumor medicaments |
| 02/01/2012 | CN102335437A Application of metadherin (MTDH) gene vaccine in preparation of breast cancer cell growth inhibitor |
| 02/01/2012 | CN102335415A Anti-inflammatory effect, implementation method and purpose of novel membrane molecule |
| 02/01/2012 | CN102335189A Medicament composition containing antisense polynucleotide targeting miR-214 |
| 02/01/2012 | CN102335135A Functionalized nanoparticle, method for preparing the same and application thereof |
| 02/01/2012 | CN101899097B 一种b血型抗原表位模拟肽及其应用 One kind of b blood group antigen epitope mimetic peptide and its application |
| 02/01/2012 | CN101897669B 一种脑靶向递药系统 Kind of brain-targeted drug delivery systems |
| 02/01/2012 | CN101805724B 靶向性wwox基因重组腺病毒及其制备方法和应用 Targeting wwox recombinant adenovirus and its preparation method and application |
| 02/01/2012 | CN101717779B 一种适用于炭疽抗毒素和疫苗的融合蛋白 One for anthrax antitoxin fusion proteins and vaccines |
| 02/01/2012 | CN101220374B 鸡痘病毒双基因表达载体（pg7.5n） FPV dual expression vector (pg7.5n) |
| 01/31/2012 | US8106251 Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 01/31/2012 | US8106182 Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field |
| 01/31/2012 | US8106181 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 01/31/2012 | US8106173 Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 |
| 01/31/2012 | US8106171 Nel-related type 1 polypeptide |
| 01/31/2012 | US8106028 MicroRNA-21 antagonists and its target PDCD4 for use in the treatment of a glioma |
| 01/31/2012 | US8106027 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106026 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106025 Method for inhibiting the activity of mir-155 |
| 01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
| 01/31/2012 | US8105610 Method of making novel erythrovirus V9 VP2 capsid polypeptides |
| 01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
| 01/31/2012 | US8105589 Use of DR3 antibodies in the treatment of inflammatory disease |
| 01/31/2012 | US8105574 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 01/31/2012 | CA2524907C Polyethylene glycol/polycation block copolymers |
| 01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
| 01/31/2012 | CA2393251C Eliciting hcv-specific antibodies |
| 01/31/2012 | CA2392221C Bovine immunodeficiency virus (biv) based vectors |
| 01/31/2012 | CA2391952C Inhibitors of histone deacetylase |
| 01/31/2012 | CA2380216C Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/26/2012 | WO2012012738A1 Genome editing using targeting endonucleases and single-stranded nucleic acids |
| 01/26/2012 | WO2012012737A2 Stable tregs and related materials and methods |
| 01/26/2012 | WO2012012710A2 Radiation sensitization agents for prostate cancer |
| 01/26/2012 | WO2012012676A2 Use of mir-29 for cell protection |
| 01/26/2012 | WO2012012667A2 Methods and compositions for modification of a hla locus |
| 01/26/2012 | WO2012012546A2 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 01/26/2012 | WO2012012541A2 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | WO2012012518A2 Inhibition of nonsense mediated decay pathways |
| 01/26/2012 | WO2012012467A2 Modulation of nuclear-retained rna |
| 01/26/2012 | WO2012012443A2 Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
| 01/26/2012 | WO2012011952A2 Copy number variant-dependent genes as diagnostic tools, predictive biomarkers and therapeutic targets |
| 01/26/2012 | WO2012011891A2 Laminates for crop protection |
| 01/26/2012 | WO2012011778A2 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer |
| 01/26/2012 | WO2012010103A1 Aptamer, method of preparing same and use of same |
| 01/26/2012 | WO2011149733A3 Novel amino alcohol cationic lipids for oligonucleotide delivery |
| 01/26/2012 | WO2011143557A3 Humanized ttc and methods of use thereof |
| 01/26/2012 | WO2011084548A3 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 01/26/2012 | US20120022136 Cellular Genes Regulated by HIV-1 Infection and Methods of Use Thereof |
| 01/26/2012 | US20120022133 Antisense modulation of cholesteryl ester transfer protein expression |
| 01/26/2012 | US20120021470 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 01/26/2012 | US20120021042 Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances |
| 01/26/2012 | US20120021039 Expression of neuropeptides in mammalian cells |
| 01/26/2012 | US20120021035 Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 01/26/2012 | US20120020956 Activation of sodium potassium atpase |
| 01/26/2012 | US20120020951 Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | US20120020939 MHC-less cells |
| 01/26/2012 | US20120020936 Treatment of neurodegenerative disease using placental stem cells |
| 01/26/2012 | US20120020924 Novel recombinant adenovirus vector having a reduced side effect |
| 01/26/2012 | US20120020915 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System |
| 01/26/2012 | US20120020890 Staphylococcus aureus proteins and nucleic acids |
| 01/26/2012 | CA2805442A1 Methods and compositions for modification of an hla locus |
| 01/25/2012 | EP2409713A1 Oligonucleotides for use in modulating lipoprotein and cholesterol levels in humans |
| 01/25/2012 | EP2408920A2 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/25/2012 | EP2408919A2 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/25/2012 | EP2408469A1 Use of decorin for increasing muscle mass |
| 01/25/2012 | EP2408467A2 A method and composition using a dual specificity protein tyrosine phosphatase as an antimalarial drug target |
| 01/25/2012 | EP1434597B1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 01/25/2012 | EP1192253B1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 01/25/2012 | CN1981872B Use of PUMA in tumor chemoradiotherapy sensibilization |
| 01/25/2012 | CN102333543A Cell adhesion inhibitor and use thereof |
| 01/25/2012 | CN102329810A siRNA conveying carrier and application thereof |
| 01/25/2012 | CN102329809A Reverse genetic operating system of canine distemper virus (CDV)/R-20/8 vaccine strain and application thereof |
| 01/25/2012 | CN102329799A Seventeen rat source miRNAs and corresponding miRNA precursors and antisense oligonucleotides thereof |
| 01/25/2012 | CN102329798A Micro RNA in taenia saginata and application thereof |
| 01/25/2012 | CN102329797A Micro RNA in taenia asiatica and application thereof |
| 01/25/2012 | CN102329794A Bcl11a siRNA-585 for inhibiting B-cell lymphoma/leukemia 11A (BCL11A) expression and tumorous B cell proliferation and application thereof |
| 01/25/2012 | CN102329386A Achistosoma japonica Ago protein, gene, micro RNA (Ribonucleic Acid) and application thereof |
| 01/25/2012 | CN102327624A Novel liposome capable of transfecting genes efficiently in vivo and in vitro and preparation method thereof |
| 01/25/2012 | CN102327623A Preparation method of DNA (deoxyribonucleic acid) vaccine nanoparticles containing PLGA (Poly-lactide-co-glycolide) for ND (necastle disease) |
| 01/25/2012 | CN102327622A Method for loading siRNA (small interfering Ribonucleic Acid) by using mesoporous silicon dioxide nanoparticles |
| 01/25/2012 | CN101890172B Application of S100A16 gene in preparing drug for treating obesity |
| 01/25/2012 | CN101822842B Reformation of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adeno-associated virus vaccine thereof |
| 01/25/2012 | CN101812177B Preparations of cationic polymer modified by steroid hormone and gene composite thereof |
| 01/25/2012 | CN101780272B Application of autovaccine preparation containing TGF beta 1 |
| 01/25/2012 | CN101550416B Humanized monoantibody Hu-ScFv18 light and heavy chain variable region gene and coding polypeptide thereof and application thereof |
| 01/25/2012 | CN101293931B Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof |
| 01/24/2012 | US8101743 Modulation of transthyretin expression |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |